Scientech Research LLC Beam Therapeutics Inc. Transaction History
Scientech Research LLC
- $485 Billion
- Q2 2024
A detailed history of Scientech Research LLC transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Scientech Research LLC holds 51,876 shares of BEAM stock, worth $1.57 Million. This represents 0.25% of its overall portfolio holdings.
Number of Shares
51,876
Previous 19,407
167.31%
Holding current value
$1.57 Million
Previous $641 Million
89.56%
% of portfolio
0.25%
Previous 0.34%
Shares
3 transactions
Others Institutions Holding BEAM
# of Institutions
230Shares Held
73.3MCall Options Held
283KPut Options Held
233K-
Farallon Capital Management LLC San Francisco, CA7.91MShares$240 Million0.9% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.9MShares$240 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$232 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl6.53MShares$198 Million1.52% of portfolio
-
Arch Venture Management, LLC Chicago, IL5.44MShares$165 Million74.72% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $2.14B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...